Table 1 Individual Patient demographics, clinical characteristics and allergen challenge information
Number of patients | 11 |
Age | 45.5 (7.2) |
Gender | Male 9 Female 2 |
Baseline FEV1 (% predicted) | 101.5 (12.3) |
Baseline FeNO (ppb) | 34.5 (20.6) |
ACQ score | 1.2 (0.6) |
Methacholine PC20 | 2.7 (2.2) |
Allergen selected for challenge | HDM 9 CAT 2 |
Cumulative Allergen Concentration Administered (SQU/mL) | 22,366.5 (27,672.3) |
Maximum % fall in FEV1 during EAR | 29.2 (3.9) |